Prothena Corp. plc buy Chardan Capital
Start price
21.02.25
/
50%
€16.20
Target price
21.02.26
€38.18
Performance (%)
-51.54%
Price
14:55
€7.85
Summary
This prediction is currently active. Massive losses of -51.54% have been the result for the BUY prediction by Chardan_Capital. This prediction currently runs until 21.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Prothena Corp. plc | -1.266% | -1.266% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by Chardan_Capital for this prediction
In the thread Prothena Corp. plc diskutieren
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Stopped prediction by Chardan_Capital for Prothena Corp. plc
Prothena Corp. plc
Start price
Target price
Perf. (%)
€14.50
20.12.24
20.12.24
€38.43
20.12.25
20.12.25
-45.86%
21.12.25
21.12.25
